Topic: metabolic syndrome
Paul-Peter Tak joins Kintai Therapeutics as it steers its “precision enteric medicines” toward the clinic, with the first trials slated to start in 2020.
A new study suggests that some gut immune cells modulate the process by which the body either stores ingested food as fat or uses it for energy.
In mouse models of obesity, the naturally occurring protein FGFBP3 drastically reduced fat mass.
Targeting a protein called sarcolipin could prompt the body to burn more fat, researchers suggest in a new study.
Scientists at American University have discovered a potential method for treating obesity.
California researchers have gained insight into how a 30-year-old asthma drug called amlexanox helps burn calories—and it all ties into inflammation.
The deal gives Boehringer access to Gubra’s expertise in the design, synthesis and preclinical testing of therapeutic peptides.
Harvard University researchers have identified an enzyme that protects cells from harmful fats, which could inform new obesity treatments.
Feinstein Institute-led researchers used an Alzheimer’s drug to reduce inflammation in people with metabolic syndrome.